Veri Medtech Holdings Inc. (VRHI.US), which operates a telehealth platform for medical cannabis patients, disclosed the terms for its initial public offering on Thursday. The company is currently traded over-the-counter under the ticker symbol "VRHI." Based in McLean, Virginia, Veri Medtech intends to offer 3.8 million shares at $4 per share, aiming to raise $15 million.

The company provides both online and in-person consultation services across multiple states. It runs the Veriheal platform, which has facilitated approvals for more than 400,000 patients and holds an approximate 5% market share in its current operational regions. Additionally, Veri Medtech operates the DosePop platform, a direct-to-consumer digital health service concentrating on weight loss, ADHD, dermatology, anti-aging, and sexual wellness.

Established in 2017, Veri Medtech Holdings reported revenue of $11 million for the twelve months ended December 31, 2025. The company plans to list on the Nasdaq exchange under the same ticker "VRHI." Network 1 Financial Securities is acting as the sole book-running manager for the offering.